Nanoviricides, Inc.
NNVC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001379006
No open-market purchases or sales by Nanoviricides, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $3.27M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Nanoviricides, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 31 | 30 | −1 |
| Shares | 1.33M | 1.36M | +34.2K (+2.6%) |
| Value | $2.30M | $1.51M | −$786.2K (−34.2%) |
New holders (5)
Institutions that held Nanoviricides, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 11,587 | $13.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 1,653 | $2.00K | 0.00% |
| Sandy Spring Bank | 265 | $294 | 0.00% |
| ICA Group Wealth Management, LLC | 200 | $283 | 0.00% |
| Advisory Services Network, LLC | 25 | $28 | 0.00% |
Sold out (6)
Institutions that held Nanoviricides, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Susquehanna International Group, LLP | 15,936 | $28.0K |
| First Financial Bank - Trust Division | 10,881 | $19.0K |
| Group One Trading, L.P. | 500 | $1.00K |
| Royal Bank of Canada | 1 | $0 |
| Gradient Investments LLC | 49 | $0 |
| IFP Advisors, Inc | 21 | – |